
Opinion|Videos|April 4, 2025
Future Breakthroughs: What’s Next for Bispecific Antibodies in Oncology?
Experts discuss innovations and advancements in bispecific antibodies that could transform their use in the next 5 years.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What innovations or advancements in bispecific antibodies could transform their use in the next 5 years?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
2
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
3
Long-Term Remission in Ph-Negative B-ALL With Sequential CAR T, ASCT
4
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
5














































